Discovery and Development of Next Generation sGC Stimulators with Diverse Multidimensional Pharmacology and Broad Therapeutic Potential
Nitric Oxide (2018)
This article provides an introduction to the central role of nitric oxide-sGC-cGMP signaling in health and disease and an overview of the sGC stimulators being developed by Cyclerion (Ironwood Pharmaceuticals at the time of publication), with an emphasis on olinciguat and praliciguat.